Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GenMark Diagnostics, Inc.

http://www.genmarkdx.com/index.php

Latest From GenMark Diagnostics, Inc.

Dealmaking Quarterly Statistics, Q1 2021: Boston Scientific, Roche Start The Year With Billion-Dollar-Plus Acquisitions

During the first quarter, medical device company mergers and acquisition totalled $10.2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $5bn.

M & A Deals

Diagnostics Saves Roche From Q1 Difficulties

In its first quarter 2021 sales earnings report, Roche highlighted the strength of its diagnostics business as biosimilars cannibalize its pharmaceutical revenues.

Sales & Earnings In Vitro Diagnostics

Deal Watch: Roche Links With SemaThera, Acquires GenMark Diagnostics

Tempest goes public via a reverse merger with Millendo. Takeda inks its ninth deal of 2021, a discovery pact with BridGene around its chemoproteomics technology.

Deals Business Strategies

Roche Buys GenMark Diagnostics For $1.8Bn

GenMark’s syndromic panel testing portfolio complements Roche’s molecular diagnostics business.

M & A Infectious Diseases
See All

Company Information

  • Other Names / Subsidiaries
    • GenMark Diagnostics Europe GmbH
UsernamePublicRestriction

Register